ELU42 Topical Spray for Foot Ulcer

This trial tests a new topical spray treatment, ELU42, to help heal chronic diabetic foot ulcers. The goal is to determine if the spray is safe and effective in reducing the size of foot wounds caused by diabetes. Participants must have had a diabetic foot ulcer for at least 4 weeks but not more than a year, with the ulcer located below the ankle. This study is ideal for those with diabetes who experience persistent foot ulcers affecting daily life. As a Phase 1, Phase 2 trial, the research focuses on understanding how ELU42 works in people and measuring its effectiveness in an initial, smaller group, offering participants a chance to be among the first to benefit from this innovative treatment.

The trial protocol does not specify if you need to stop your current medications. However, if you recently needed antibiotics for an infection, you must wait 7 days after stopping them before joining the trial.

Research has shown that ELU42, a spray for treating long-lasting diabetic foot sores, is currently undergoing safety testing in clinical trials. This treatment contains two main ingredients: one that controls cell growth and another, a modified form of a natural substance in the body, that aids healing.

As ELU42 is in the early testing stages, researchers are closely monitoring its safety. Although extensive human safety data is not yet available, reaching this stage indicates that earlier studies or lab tests deemed it safe enough for human trials. Participants will be carefully monitored for any side effects while using the spray on their foot sores.

Unlike traditional treatments for diabetic foot ulcers, which often involve dressings and systemic antibiotics, ELU42 is a topical spray that directly targets the ulcer. Researchers are excited about ELU42 because it offers a new delivery method that could enhance healing by working right at the site of the wound. This direct application can potentially reduce side effects and improve patient comfort and compliance.

Research shows that ELU42 aims to heal chronic diabetic foot ulcers by altering a crucial process for cell growth and healing. Early studies have shown that the main ingredient in ELU42, which blocks a specific enzyme, helps wounds heal. The treatment also includes a special type of hyaluronic acid, known for keeping tissues moist and aiding in healing. Although human studies provide limited data, this combination is expected to improve ulcer healing by enhancing tissue repair and maintaining moisture. Initial findings suggest this could be a promising approach for chronic diabetic foot ulcers.¹²³⁶⁷